Printer Friendly

SYNCOR APPOINTS HENRY N. WAGNER, JR., M.D. TO BOARD OF DIRECTORS

 SYNCOR APPOINTS HENRY N. WAGNER, JR., M.D. TO BOARD OF DIRECTORS
 NEW YORK, June 4 /PRNewswire/ -- At the PaineWebber Emerging Growth conference, Syncor International (NASDAQ: SCOR) today announced the election of Henry N. Wagner, Jr., M.D., to the company's board of directors. This position, previously unfilled, brings the total number of directors to seven.
 "We are fortunate to have Dr. Wagner join our board of directors," said Gene McGrevin, president and chief executive officer of Syncor International. "He will add a wealth of knowledge and experience to our board."
 Considered by some as the "Father of Nuclear Medicine," Dr. Wagner has spent more than 30 years at the Johns Hopkins University, pioneering radioactive diagnostics and treatments. He is currently a professor of Medicine, Radiology and Radiological Science and Environmental Health Sciences, as well as the director of Nuclear Medicine and Radiology and Radiological Science and Environmental Health Sciences at the University. At Johns Hopkins Hospital, he is director of the Division of Nuclear Medicine.
 Wagner and his work have been nationally and internationally recognized with numerous honors and awards, including the prestigious American Medical Association's Scientific Achievement Award. Wagner is a member of many professional societies and sits on several research committees for such organizations as the National Institutes of Health, National Research Council and the Nuclear Regulatory Commission.
 Syncor International operates an expanded nationwide network of 94 nuclear pharmacy service centers and 14 home care pharmacies. The company prepares and delivers patient specific intravenous drugs and solutions for use in diagnostic imaging and a complete range of products for infusion therapy. Syncor services over 6,000 hospitals, clinics, physicians' offices, nursing facilities, and home-based patients. Syncor is the only national pharmacy network of its kind that provides this combination of diagnostic, therapeutic, and monitoring services to hospitals and alternate site markets.
 -0- 6/4/92
 /CONTACT: Michael E. Mikity, vice president of Syncor International, 818-886-7400, or Susan Noonan or Anthony J. Russo of Noonan/Russo Communications, 212-979-9180, for Syncor International/
 (SCOR) CO: Syncor International Corporation ST: California IN: MTC SU: PER


TQ-OS -- NY058 -- 7089 06/04/92 13:38 EDT
COPYRIGHT 1992 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1992 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Jun 4, 1992
Words:353
Previous Article:PARAMOUNT PROMOTES BENDER TO VICE PRESIDENT, LATIN AMERICAN SALES
Next Article:PHILADELPHIA ELECTRIC SELLS $125 MILLION OF MORTGAGE BONDS THROUGH COMPETITIVE BIDDING
Topics:

Terms of use | Copyright © 2016 Farlex, Inc. | Feedback | For webmasters